Global Information
회사소개 | 문의 | 비교리스트

세계의 저분자량 헤파린 시장 예측(-2028년) : COVID-19의 영향과 분석 - 제품 유형별, 포장별, 용도별, 최종사용자별, 지역별

Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Packaging, Application, and End User, and Geography

리서치사 The Insight Partners
발행일 2021년 12월 상품코드 1059335
페이지 정보 영문 191 Pages 배송안내
가격
US $ 4,550 ₩ 5,797,000 PDF (Single User License)
US $ 6,550 ₩ 8,346,000 PDF (Site License)
US $ 8,550 ₩ 10,894,000 PDF (Enterprise License)


세계의 저분자량 헤파린 시장 예측(-2028년) : COVID-19의 영향과 분석 - 제품 유형별, 포장별, 용도별, 최종사용자별, 지역별 Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Packaging, Application, and End User, and Geography
발행일 : 2021년 12월 페이지 정보 : 영문 191 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 저분자량 헤파린 시장 규모는 2021년에 36억 5,827만 달러로 평가되었습니다. 2021-2028년간 시장은 6.6%의 연평균 복합 성장률(CAGR)로 확대되어 2028년에는 57억 3,396만 달러에 이를 것으로 예측됩니다.

세계의 저분자량 헤파린(Low Molecular Weight Heparin) 시장에 대해 조사했으며, 시장 개요, 제품 유형별/포장별/용도별/종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서론

제2장 중요한 포인트

제3장 조사 방법

제4장 저분자량 헤파린 시장 : 시장 구도

  • 개요
  • PEST 분석
  • 전문가의 견해

제5장 저분자량 헤파린 시장 : 주요 시장 역학

  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회
  • 향후 동향
  • 영향 분석

제6장 저분자량 헤파린 시장 : 세계 분석

  • 세계의 저분자량 헤파린 시장 매출 예측과 분석
  • 주요 시장 진출기업의 시장 포지셔닝

제7장 세계의 저분자량 헤파린 시장 매출과 예측(-2028년) : 제품 유형별

  • 개요
  • 세계의 저분자량 헤파린 시장, 제품 유형별, 2021년 및 2028년(%)
  • Enoxaparin
  • Dalteparin
  • Nadroparin
  • Fraxiparine
  • Tinzaparin
  • 기타

제8장 저분자량 헤파린 시장 매출과 예측(-2028년) : 포장별

  • 개요
  • 세계의 저분자량 헤파린 시장 점유율, 포장별, 2021년과 2028년(%)
  • Multi-Vials
  • 프리필드 시린지

제9장 세계의 저분자량 헤파린 시장 매출과 예측(-2028년) : 용도별

  • 개요
  • 세계의 저분자량 헤파린 시장, 용도별, 2021년 및 2028년(%)
  • 심부정맥혈전증
  • 급성관증후군(ACS)
  • 폐색전증
  • 기타

제10장 세계의 저분자량 헤파린 시장 매출과 예측(-2028년) : 최종사용자별

  • 개요
  • 세계의 저분자량 헤파린 시장, 최종사용자별, 2021년 및 2028년(%)
  • 병원
  • 클리닉
  • 외래수술센터(ASC)
  • 기타

제11장 저분자량 헤파린 시장 매출과 예측(-2028년) : 지역별 분석

  • 북미 : 저분자량 헤파린 시장
  • 유럽 : 저분자량 헤파린 시장 매출과 예측(-2028년)
  • 아시아태평양 : 저분자량 헤파린 시장
  • 중동 및 아프리카 : 저분자량 헤파린 시장
  • 중남미 : 저분자량 헤파린 시장

제12장 세계 저분자량 헤파린 시장에 대한 COVID-19 팬데믹의 영향

  • 북미 : COVID-19 팬데믹의 영향 평가
  • 유럽 : COVID-19 팬데믹의 영향 평가
  • 아시아태평양 : COVID-19 팬데믹의 영향 평가
  • 중동 및 아프리카 : COVID-19 팬데믹의 영향 평가
  • 중남미 : COVID-19 팬데믹의 영향 평가

제13장 저분자량 헤파린 시장 : 업계 상황 전망

  • 개요
  • 저분자량 헤파린 시장 성장 전략(%)
  • 유기적 개발
  • 무기적 개발

제14장 기업 개요

  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Abbott
  • Novartis AG
  • Sanofi
  • Pfizer Inc.
  • B. Braun Medical Inc.
  • Dr. Reddy's Laboratories
  • LEO Pharma A/S
  • Aspen Holdings
  • Changzhou Qianhong Biopharma Co Ltd

제15장 부록

LSH 22.03.10

List Of Tables

  • Table 1. North America Low Molecular Weight Heparin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Low Molecular Weight Heparin Market, by End Use, - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Low Molecular Weight Heparin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US: Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US: Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US: Low Molecular Weight Heparin Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada: Low Molecular Weight Heparin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada: Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada: Low Molecular Weight Heparin Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico: Low Molecular Weight Heparin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Mexico: Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico: Low Molecular Weight Heparin Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Europe Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Product Type (US$ Mn).
  • Table 18. Europe Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Europe Low Molecular Weight Heparin Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Europe Low Molecular Weight Heparin Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Product Type(US$ Mn)
  • Table 22. Germany Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Germany: Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Germany: Low Molecular Weight Heparin Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. France: Low Molecular Weight Heparin Market, By Product Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 26. France Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 27. France Low Molecular Weight Heparin Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 28. France Low Molecular Weight Heparin Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. UK: Low Molecular Weight Heparin Market, By Product Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 30. UK Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 31. UK: Low Molecular Weight Heparin Market, By Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 32. UK: Low Molecular Weight Heparin Market, By Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Italy: Low Molecular Weight Heparin Market, By Product Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Italy Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Italy Low Molecular Weight Heparin Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Italy Low Molecular Weight Heparin Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Spain: Low Molecular Weight Heparin Market, By Product Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Spain Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Spain Low Molecular Weight Heparin Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Spain Low Molecular Weight Heparin Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Rest of Europe: Low Molecular Weight Heparin Market, By Product Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Rest of Europe Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Rest of Europe Low Molecular Weight Heparin Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Rest of Europe Low Molecular Weight Heparin Market, by Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Asia Pacific: Low Molecular Weight Heparin Market, By Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. Asia Pacific: Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Asia Pacific: Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Asia Pacific Low Molecular Weight Heparin Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 49. China: Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. China: Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. China: Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. China: Low Molecular Weight Heparin Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Japan: Low Molecular Weight Heparin Market, By Product type- Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Japan: Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Japan: Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Japan: Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. India: Low Molecular Weight Heparin Market, By Product type- Revenue and Forecast to 2028 (US$ Million)
  • Table 58. India: Low Molecular Weight Heparin Market, By Packaging- Revenue and Forecast to 2028 (US$ Million)
  • Table 59. India: Low Molecular Weight Heparin Market, By Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 60. India: Low Molecular Weight Heparin Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Australia: Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Australia: Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Australia: Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Australia: Low Molecular Weight Heparin Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 65. South Korea: Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. South Korea: Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. South Korea: Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. South Korea: Low Molecular Weight Heparin Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Rest of Asia Pacific: Low Molecular Weight Heparin Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Middle East & Africa Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Middle East & Africa Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Middle East & Africa Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Middle East & Africa Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Saudi Arabia Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Saudi Arabia Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Saudi Arabia Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Saudi Arabia Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. UAE Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. UAE Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. UAE Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 84. UAE Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 85. South Africa Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 86. South Africa Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. South Africa Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 88. South Africa Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 89. Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 90. Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 91. Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 92. Rest of Middle East & Africa Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 93. South and Central America Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 94. South and Central America Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 95. South and Central America Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 96. South and Central America Low Molecular Weight Heparin Market, By End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 97. Brazil Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 98. Brazil Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 99. Brazil Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 100. Brazil Low Molecular Weight Heparin Market, By End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 101. Argentina Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 102. Argentina Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 103. Argentina Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 104. Argentina Low Molecular Weight Heparin Market, By End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 105. Rest of South and Central America Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 106. Rest of South and Central America Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
  • Table 107. Rest of South and Central America Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 108. Rest of South and Central America Low Molecular Weight Heparin Market, By End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 109. Organic Developments in the Low Molecular Weight Heparin Market
  • Table 110. Inorganic Developments in the Low Molecular Weight Heparin Market
  • Table 111. Glossary of Terms, Low Molecular Wight Heparin Market

List Of Figures

  • Figure 1. Low Molecular Weight Heparin Market Segmentation
  • Figure 2. Low Molecular Weight Heparin Market, By Region
  • Figure 3. Global Low Molecular Weight Heparin Market Overview
  • Figure 4. Enoxaparin Segment Held Largest Share of Product Type Segment in Low Molecular Weight Heparin Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Low Molecular Weight Heparin Market, by Geography (US$ Million)
  • Figure 7. Global Low Molecular Weight Heparin Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Low Molecular Weight Heparin Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Low Molecular Weight Heparin Market Impact Analysis of Driver and Restraints
  • Figure 16. Global Low Molecular Weight Heparin Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Low Molecular Weight Heparin Market- Revenue Forecast and Analysis - 2021 & 2028
  • Figure 18. Market Positioning of Key Players in Global Low Molecular Weight Heparin Market
  • Figure 19. Global Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)
  • Figure 20. Enoxaparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Dalteparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Nadroparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Fraxiparine: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Tinzaparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Global LMWH Market Share by Packaging - 2021 & 2028 (%)
  • Figure 27. Multi-Vials: Low Molecular Weight Heparin Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 28. Prefilled Syringes: Low Molecular Weight Heparin Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 29. Global Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)
  • Figure 30. Deep Vein Thrombosis: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Acute Coronary Syndrome (ACS): Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Pulmonary Embolism: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Global Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)
  • Figure 35. Hospitals: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Clinics: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Ambulatory Surgical Centers: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. North America: Low Molecular Weight Heparin Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 40. North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. North America: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
  • Figure 42. US: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Canada: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Mexico: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Europe: Low Molecular Weight Heparin Market Revenue Overview, by Country, 2021 (US$ MN)
  • Figure 46. Europe: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 47. Europe Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Country (%)
  • Figure 48. Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 49. France: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. UK: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Italy: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Spain: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Rest of Europe: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Asia Pacific: Low Molecular Weight Heparin Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 55. Asia Pacific Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Asia Pacific: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
  • Figure 57. China: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Japan: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. India: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Australia: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. South Korea: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Rest of Asia Pacific: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Middle East & Africa: Low Molecular Weight Heparin Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 64. Middle East & Africa Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. Middle East & Africa: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
  • Figure 66. Saudi Arabia: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. UAE: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. South Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. Rest of Middle East and Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. South and Central America: Low Molecular Weight Heparin Market, By Key Country - Revenue (2021) (US$ Million)
  • Figure 71. South and Central America: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (US$ Million)
  • Figure 72. South and Central America: Low Molecular Weight Heparin Market Share by Country - 2021 & 2028, (%)
  • Figure 73. Brazil: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (US$ Million)
  • Figure 74. Argentina: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (US$ Million)
  • Figure 75. Rest of SCAM: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 76. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 77. Impact Of COVID-19 Pandemic in Europe Country Markets

Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  • Figure 78. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 79. Impact Of COVID-19 Pandemic in South & Central America Country Markets

The low molecular weight heparin market is expected to grow from US$ 3,658.27 million in 2021 to US$ 5,733.96 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028.

Low molecular weight heparin (LMWH) is a class of anticoagulants. They are used to treat venous thromboembolism (deep vein thrombosis and pulmonary embolism) and myocardial infarction, and prevent blood clots. Low molecular weight heparin offers more advantages than heparin as it has better bioavailability, longer half-life, simplified dosing, predictable anticoagulant response, lower HIT risk, and lower osteoporosis risk.

LMWH can be administered subcutaneously once or twice daily without coagulation monitoring, even when the drug is administered in treatment doses. Most patients do not require coagulation monitoring with LMWH. The effects of unfractionated heparin (UFH) or standard heparin vary from patient to patient. Therefore, it can only be administered to hospitalized patients under supervision. In addition, the LMWH has more predictable pharmacokinetic properties than unfractionated heparin, which allows its administration in fixed doses based on laboratory monitoring, without the need for dose adjustments.

The low molecular weight fractions of heparin have the molecular weight of ~3,500-8,000 Daltons, while unfractionated heparin has a molecular weight of 15,000 Daltons; thus, the former react less with platelets than the latter. Moreover, the LMWH is less likely to induce immune allergic thrombocytopenia, which is a severe side effect of unfractionated heparin (UFH). This condition is often complicated by arterial thrombosis. In addition, various properties such as better bioavailability, predictable dose-response, and longer plasma half-life than unfractionated heparin make low molecular weight heparin a preferred choice for anticoagulation therapy. Such advantages of the LMWH over unfractionated heparin are boosting its demand, thereby spurring the market growth.

The global low molecular weight heparin market, based on Product type, has been segmented into The global low molecular weight heparin market, based on product type, is segmented into enoxaparin, dalteparin, tinzaparin, fraxiparine, nadroparin, and others. The enoxaparin segment held the largest share of the market in 2021. However, the dalteparin segment is anticipated to register the highest CAGR of 7.1% in the market during the forecast period.

The global low molecular weight heparin market, based on packaging, is bifurcated into multi-vials and prefilled syringes. In 2021, the multi-vials segment held a larger share of the market, whereas the prefilled syringes segment is expected to register the highest CAGR during 2021-2028.

The global low molecular weight heparin market, based on application, has been segmented into deep vein thrombosis, acute coronary syndrome (ACS), pulmonary embolism, and others. The deep vein thrombosis segment held the largest share of the market in 2021. However, the acute coronary syndrome (ACS) segment is anticipated to register the highest CAGR in the market during the forecast period.

The global low molecular weight heparin market, based on end user, has been segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2021. However, the ambulatory surgical centers segment is anticipated to register the highest CAGR in the market during the forecast period.

National Institutes of Health (NIH), National Healthcare Service (NHS), Centers for Disease Control and Prevention (CDC), National Chronic Kidney Disease, National Center for Biotechnology Information, National Statistics Institute, and World Health Organization (WHO) are a few of the major secondary sources referred to while preparing the report on the low molecular weight heparin market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Low Molecular Weight Heparin market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global Low Molecular Weight Heparin market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Low Molecular Weight Heparin Market - By Product
    • 1.3.2 Global Low Molecular Weight Heparin Market - By Packaging
    • 1.3.3 Global Low Molecular Weight Heparin Market - By Application
    • 1.3.4 Global Low Molecular Weight Heparin Market - By End User
    • 1.3.5 Global Low Molecular Weight Heparin Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Low Molecular Weight Heparin Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Experts Opinion

5. Low Molecular Weight Heparin Market- Key Market Dynamics

  • 5.1 Market Drivers
  • 5.2 Market Restraints
  • 5.3 Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis

6. Low Molecular Weight Heparin Market- Global Analysis

  • 6.1 Global Low Molecular Weight Heparin Market Revenue Forecast and Analysis
  • 6.2 Global Low Molecular Weight Heparin Market Revenue Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Global Low Molecular Weight Heparin Market Revenue and Forecast To 2028- By Product Type

  • 7.1 Overview
  • 7.2 Global Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)
  • 7.3 Enoxaparin
    • 7.3.1 Overview
    • 7.3.2 Enoxaparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Dalteparin
    • 7.4.1 Overview
    • 7.4.2 Dalteparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Nadroparin
    • 7.5.1 Overview
    • 7.5.2 Nadroparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Fraxiparine
    • 7.6.1 Overview
    • 7.6.2 Fraxiparine: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Tinzaparin
    • 7.7.1 Overview
    • 7.7.2 Tinzaparin: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

8. Low Molecular Weight Heparin Market Revenue and Forecast To 2028 - Packaging

  • 8.1 Overview
  • 8.2 Global Low Molecular Weight Heparin Market Share by Packaging - 2021 & 2028 (%)
  • 8.3 Multi-Vials
    • 8.3.1 Overview
    • 8.3.2 Multi-Vials: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Prefilled Syringes
    • 8.4.1 Overview
    • 8.4.2 Prefilled Syringes: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9. Global Low Molecular Weight Heparin Market Revenue and Forecast To 2028- By Application

  • 9.1 Overview
  • 9.2 Global Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)
  • 9.3 Deep Vein Thrombosis
    • 9.3.1 Overview
    • 9.3.2 Deep Vein Thrombosis: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Acute Coronary Syndrome (ACS)
    • 9.4.1 Overview
    • 9.4.2 Acute Coronary Syndrome (ACS): Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Pulmonary Embolism
    • 9.5.1 Overview
    • 9.5.2 Pulmonary Embolism: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10. Global Low Molecular Weight Heparin Market Revenue and Forecast To 2028- By End User

  • 10.1 Overview
  • 10.2 Global Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Clinics
    • 10.4.1 Overview
    • 10.4.2 Clinics: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Ambulatory Surgical Centers
    • 10.5.1 Overview
    • 10.5.2 Ambulatory Surgical Centers: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

11. Low Molecular Weight Heparin Market Revenue and Forecast to 2028 - Geographical Analysis

  • 11.1 North America: Low Molecular Weight Heparin Market
    • 11.1.1 Overview
    • 11.1.2 North America: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.1.3 North America: Low Molecular Weight Heparin Market, by Product Type, 2019-2028 (US$ Million)
    • 11.1.4 North America: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
    • 11.1.5 North America: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
    • 11.1.6 North America: Low Molecular Weight Heparin Market, by End Use, 2019-2028 (US$ Million)
    • 11.1.7 North America: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
      • 11.1.7.1 US: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.1 US: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.2 US: Low Molecular Weight Heparin Market, by Product Type, 2019-2028 (US$ Million)
        • 11.1.7.1.3 US: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
        • 11.1.7.1.4 US: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
        • 11.1.7.1.5 US: Low Molecular Weight Heparin Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.7.2 Canada: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.1 Canada: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.2 Canada: Low Molecular Weight Heparin Market, by Product Type, 2019-2028 (US$ Million)
        • 11.1.7.2.3 Canada: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
        • 11.1.7.2.4 Canada: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
        • 11.1.7.2.5 Canada: Low Molecular Weight Heparin Market, by End Use, 2019-2028 (US$ Million)
    • 11.1.8 Mexico: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.8.1 Mexico: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.8.2 Mexico: Low Molecular Weight Heparin Market, by Product Type, 2019-2028 (US$ Million)
      • 11.1.8.3 Mexico: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
      • 11.1.8.4 Mexico: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
      • 11.1.8.5 Mexico: Low Molecular Weight Heparin Market, by End Use, 2019-2028 (US$ Million)
  • 11.2 Europe: Low Molecular Weight Heparin Market Revenue and Forecast to 2028
    • 11.2.1 Overview
    • 11.2.2 Europe: Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
    • 11.2.3 Europe Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Product Type(US$ Mn)
    • 11.2.4 Europe: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
    • 11.2.5 Europe: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
    • 11.2.6 Europe: Low Molecular Weight Heparin Market, by End Use, 2019-2028 (US$ Million)
    • 11.2.7 Europe Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Country (%)
      • 11.2.7.1 Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.2.7.1.1 Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.2.7.1.2 Germany Low Molecular Weight Heparin Market Revenue and Forecast to 2028, By Product Type(US$ Mn)
        • 11.2.7.1.3 Germany: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
        • 11.2.7.1.4 Germany: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
        • 11.2.7.1.5 Germany: Low Molecular Weight Heparin Market, by End Use, 2019-2028 (US$ Million)
      • 11.2.7.2 France Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.2.7.2.1 France: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.2 France Low Molecular Weight Heparin : Market, By Product Type, 2019-2028 (US$ Million)
        • 11.2.7.2.3 France: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
        • 11.2.7.2.4 France: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
        • 11.2.7.2.5 France: Low Molecular Weight Heparin Market, by End Use, 2019-2028 (US$ Million)
      • 11.2.7.3 UK: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.1 UK: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.2 UK: Low Molecular Weight Heparin Market, By Product Type, 2019-2028 (US$ Million)
        • 11.2.7.3.3 UK: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
        • 11.2.7.3.4 UK: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
        • 11.2.7.3.5 UK: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
      • 11.2.7.4 Italy: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.1 Italy: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.2 Italy: Low Molecular Weight Heparin Market, By Product Type, 2019-2028 (US$ Million)
        • 11.2.7.4.3 Italy: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
        • 11.2.7.4.4 Italy: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
        • 11.2.7.4.5 Italy: Low Molecular Weight Heparin Market, by End Use, 2019-2028 (US$ Million)
      • 11.2.7.5 Spain: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.1 Spain: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.2 Spain: Low Molecular Weight Heparin Market, By Product Type, 2019-2028 (US$ Million)
        • 11.2.7.5.3 Spain: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
        • 11.2.7.5.4 Spain: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
        • 11.2.7.5.5 Spain: Low Molecular Weight Heparin Market, by End Use, 2019-2028 (US$ Million)
      • 11.2.7.6 Rest of Europe: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.1 Rest of Europe: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.2 Rest of Europe: Low Molecular Weight Heparin Market, By Product Type, 2019-2028 (US$ Million)
        • 11.2.7.6.3 Rest of Europe: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
        • 11.2.7.6.4 Rest of Europe: Low Molecular Weight Heparin Market, by Application, 2019-2028 (US$ Million)
        • 11.2.7.6.5 Rest of Europe: Low Molecular Weight Heparin Market, by Packaging, 2019-2028 (US$ Million)
  • 11.3 Asia Pacific: Low Molecular Weight Heparin Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.3.3 Asia Pacific: Low Molecular Weight Heparin Market, By Product Type, 2019-2028 (US$ Million)
    • 11.3.4 Asia Pacific: Low Molecular Weight Heparin Market, By Packaging, 2019-2028 (US$ Million)
    • 11.3.5 Asia Pacific: Low Molecular Weight Heparin Market, By Application, 2019-2028 (US$ Million)
    • 11.3.6 Asia Pacific: Low Molecular Weight Heparin Market, by End User, 2019-2028 (US$ Million)
    • 11.3.7 Asia Pacific: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
      • 11.3.7.1 China: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.1.1 China: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.1.2 China: Low Molecular Weight Heparin Market, By Product type, 2019-2028 (US$ Million)
        • 11.3.7.1.3 China: Low Molecular Weight Heparin Market, By Packaging, 2019-2028 (US$ Million)
        • 11.3.7.1.4 China: Low Molecular Weight Heparin Market, By Application, 2019-2028 (US$ Million)
        • 11.3.7.1.5 China: Low Molecular Weight Heparin Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.2 Japan: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.2.1 Japan: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.2.2 Japan: Low Molecular Weight Heparin Market, By Product type, 2019-2028 (US$ Million)
        • 11.3.7.2.3 Japan: Low Molecular Weight Heparin Market, By Packaging, 2019-2028 (US$ Million)
        • 11.3.7.2.4 Japan: Low Molecular Weight Heparin Market, By Application, 2019-2028 (US$ Million)
        • 11.3.7.2.5 Japan: Low Molecular Weight Heparin Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.3 India: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.3.1 India: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.3.2 India: Low Molecular Weight Heparin Market, By Product Type, 2019-2028 (US$ Million)
        • 11.3.7.3.3 India: Low Molecular Weight Heparin Market, By Packaging, 2019-2028 (US$ Million)
        • 11.3.7.3.4 India: Low Molecular Weight Heparin Market, By Application, 2019-2028 (US$ Million)
        • 11.3.7.3.5 India: Low Molecular Weight Heparin Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.4 Australia: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.4.1 Australia: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.4.2 Australia: Low Molecular Weight Heparin Market, By Product type, 2019-2028 (US$ Million)
        • 11.3.7.4.3 Australia: Low Molecular Weight Heparin Market, By Packaging, 2019-2028 (US$ Million)
        • 11.3.7.4.4 Australia: Low Molecular Weight Heparin Market, By Application, 2019-2028 (US$ Million)
        • 11.3.7.4.5 Australia: Low Molecular Weight Heparin Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.5 South Korea: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.5.1 South Korea: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.5.2 South Korea: Low Molecular Weight Heparin Market, By Product type, 2019-2028 (US$ Million)
        • 11.3.7.5.3 South Korea: Low Molecular Weight Heparin Market, By Packaging, 2019-2028 (US$ Million)
        • 11.3.7.5.4 South Korea: Low Molecular Weight Heparin Market, By Application, 2019-2028 (US$ Million)
        • 11.3.7.5.5 South Korea: Low Molecular Weight Heparin Market, by End User, 2019-2028 (US$ Million)
      • 11.3.7.6 Rest of Asia Pacific: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.6.1 Rest of Asia Pacific: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.7.6.2 Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Product type, 2019-2028 (US$ Million)
        • 11.3.7.6.3 Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Packaging, 2019-2028 (US$ Million)
        • 11.3.7.6.4 Rest of Asia Pacific: Low Molecular Weight Heparin Market, By Application, 2019-2028 (US$ Million)
        • 11.3.7.6.5 Rest of Asia Pacific: Low Molecular Weight Heparin Market, by End User, 2019-2028 (US$ Million)
  • 11.4 Middle East & Africa: Low Molecular Weight Heparin Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.3 Middle East & Africa Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.4 Middle East & Africa Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.5 Middle East & Africa Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.6 Middle East & Africa Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.7 Middle East & Africa: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)
      • 11.4.7.1 Saudi Arabia: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.1 Saudi Arabia: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.2 Saudi Arabia Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.3 Saudi Arabia Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.4 Saudi Arabia Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.1.5 Saudi Arabia Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 11.4.7.2 UAE: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.1 UAE: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.2 UAE Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.3 UAE Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.4 UAE Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.2.5 UAE Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 11.4.7.3 South Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.1 South Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.2 South Africa Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.3 South Africa Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.4 South Africa Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.3.5 South Africa Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 11.4.7.4 Rest of Middle East and Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.1 Rest of Middle East and Africa: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.2 Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.3 Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Packaging - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.4 Rest of Middle East & Africa Low Molecular Weight Heparin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
        • 11.4.7.4.5 Rest of Middle East & Africa Low Molecular Weight Heparin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 11.5 South and Central America: Low Molecular Weight Heparin Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.5.3 South and Central America Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
    • 11.5.4 South and Central America Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
    • 11.5.5 South and Central America Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
    • 11.5.6 South and Central America Low Molecular Weight Heparin Market, By End User - Revenue and Forecast to 2028 (US$ Million)
    • 11.5.7 South and Central America: Low Molecular Weight Heparin Market Share by Country - 2021 & 2028, (%)
      • 11.5.7.1 Brazil: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (US$ Million)
        • 11.5.7.1.1 Brazil: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (US$ Million)
        • 11.5.7.1.2 Brazil Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.3 Brazil Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.4 Brazil Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.5 Brazil Low Molecular Weight Heparin Market, By End User - Revenue and Forecast to 2028 (US$ Million)
      • 11.5.7.2 Argentina: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (US$ Million)
        • 11.5.7.2.1 Argentina: Low Molecular Weight Heparin Market- Revenue and Forecast To 2028 (US$ Million)
        • 11.5.7.2.2 Argentina Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.3 Argentina Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.4 Argentina Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.5 Argentina Low Molecular Weight Heparin Market, By End User - Revenue and Forecast to 2028 (US$ Million)
      • 11.5.7.3 Rest of South and Central America: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.1 Rest of South and Central America: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.2 Rest of South and Central America Low Molecular Weight Heparin Market, By Product type - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.3 Rest of South and Central America Low Molecular Weight Heparin Market, By Packaging - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.4 Rest of South and Central America Low Molecular Weight Heparin Market, By Application - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.5 Rest of South and Central America Low Molecular Weight Heparin Market, By End User - Revenue and Forecast to 2028 (US$ Million)

12. Impact of COVID-19 Pandemic on Global Low Molecular Weight Heparin Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 12.5 South and Central America: Impact Assessment of COVID-19 Pandemic

13. Low Molecular Weight Heparin Market-Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Low Molecular Weight Heparin Market (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 TEVA PHARMACEUTICAL INDUSTRIES LTD
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Abbott
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Novartis AG
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Sanofi
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Pfizer Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 B. Braun Medical Inc.
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Dr. Reddy's Laboratories
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 LEO Pharma A/S
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Aspen Holdings
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Changzhou Qianhong Biopharma Co Ltd
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms
Back to Top
전화 문의
F A Q